Extracorporeal Membrane Oxygenation Machine Market surpassed USD 230 Mn in 2021, owing to rising prevalence of cardiopulmonary and respiratory diseases | insightSLICE
The global Extracorporeal Membrane Oxygenation Machine market size was estimated to be US$ 230 million in 2021 and is expected grow at a CAGR of 7% between 2023 to 2032.
In the report on the Extracorporeal Membrane Oxygenation Machine Market, we discuss the trends and analyses of the global market with a prediction for 2022–2032.
In addition to taking into account the competitive climate, the forecast study will contain a summary of the key players in the worldwide in vitro fertilization (IVF) market along with their market projections.
Access the sample report: https://www.insightslice.com/request-sample/318
The report would also cover notable developments, regional and global sales subsidiaries, corporate strategies, R&D projects, staff size, and chief employees for all leading market participants.
For example, Medtronic plc recorded sales of USD 30,557 million in 2019, and according to the firm’s evaluation of its market sectors, the company’s Cardiac & Vascular business segment accounted for the majority of sales.
The key players of the Global Extracorporeal Membrane Oxygenation Machine Market are:
Key companies involved in the global extracorporeal membrane oxygenation machine market are Microport Scientific Corporation, Medos Medizintechnik AG, Medtronic plc, Nipro Medical Corporation, Terumo Cardiovascular Systems Corporation, Sorin Group, and MAQUET Holding B.V. & Co. KG.
Rise in the usage of extracorporeal membrane oxygenation (ECMO) machine:
A life-support device called extracorporeal membrane oxygenation (ECMO) machine is utilized as a heart-lung bypass in situations where the heart and lungs have suffered severe damage. The heart and lungs can rest while the ECMO equipment pumps and oxygenates the patient’s blood from outside of the body.
When a patient is hooked up to an ECMO device, tubes carry the patient’s blood to a mechanical lung, which removes carbon dioxide from the blood and adds oxygen. The patient’s body is then injected with this blood after it has been heated to body temperature.
When the heart cannot circulate sufficient blood throughout the body or when the lungs cannot extract enough carbon dioxide from the blood despite the assistance of a ventilator, the ECMO machines serve a critical role for such intensive care patients.
The fatality rate from cardiovascular and pulmonary illnesses has grown as more people with these disorders are diagnosed. Extracorporeal membrane oxygenation (ECMO) equipment demand is anticipated to increase in the upcoming years as a result of concerted efforts to lower the mortality rate from cardiac and lung failure.
Read more about the report inclusions: https://www.insightslice.com/extracorporeal-membrane-oxygenation-machine-market
ECMO market analysis and statistics:
The report would determine the sectors concentrating on extracorporeal membrane oxygenation machines as well as provide an in-depth examination of the major companies that control the majority of the worldwide market share across all functioning business segments.
The report will also include the market shares of significant manufacturers in the extracorporeal membrane oxygenation machine market. As an example from this report, the core businesses of Medtronic plc are the Cardiac & Vascular Group, the Minimally Invasive Therapies Group, the Restorative Therapies Group, and the Diabetes Group.
Extracorporeal membrane oxygenation devices are provided by the corporation’s Cardiac & Vascular Group, which contributed US$11,505 million in revenue in 2019.
Crucial determinant statistics, including corporate strategies, service offerings, key developments, SWOT analysis, including research & design goals of all extracorporeal membrane oxygenation device businesses, are taken into account in the study.
The players involved in the market’s supply chain and value chain, as well as their contributions, will be taken into account in the global extracorporeal membrane oxygenation machine market research. All the company’s extracorporeal membrane oxygenation machine market business divisions will be the main emphasis of the product range.
Comparable to this, the recent developments segment will indeed concentrate on the most recent company developments, including global expansion, product launches, mergers and acquisitions, strategic partners and alliances, and geospatial coalitions in the market for extracorporeal membrane oxygenation machines.
Global Optic Nerve Disorders Treatment Market: https://www.insightslice.com/optic-nerve-disorders-treatment-market
Global Retinal Disorder Treatment Market: https://www.insightslice.com/retinal-disorder-treatment-market
Global Extracorporeal Membrane Oxygenation Machine Market Key Segments:
By Patient Type
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Rest of South America
North America and Asia Pacific are expected to lead the growth:
The extracorporeal membrane oxygenation machine market in North America represented the largest share internationally and is predicted to continue to hold this position during the forecast period.
The presence of the major ECMO manufacturers as well as the growing number of individuals with cardiorespiratory problems are the main drivers of the ECMO machine market’s expansion in North America.
Due to targeted medical infrastructure investment efforts and a growing number of individuals with cardiorespiratory illnesses, the Asia Pacific ECMO machine market is predicted to have profitable growth over the forecast period.
Proceed to purchase: https://www.insightslice.com/buy-now/318
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at email@example.com.
+1 707 736 6633